SCHEMBL3939641

SCHEMBL3939641

CC(C)(C)CNC(=O)C1c2ccccc2C(=O)N1Cc1ccccc1-c1ccccc1

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 20/20 0.77
KCNH2 Q12809 10/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3751657 0.88 KCNA5 (0.74) KCNA5KCNH2
SCHEMBL3749157 0.87 KCNA5 (1.00) KCNA5KCNH2
SCHEMBL3748753 0.86 KCNA5 (0.71) KCNA5KCNH2
SCHEMBL3754328 0.85 KCNA5 (0.71) KCNA5KCNH2
SCHEMBL3751985 0.84 KCNA5 (0.86) KCNA5KCNH2
SCHEMBL3752692 0.84 KCNA5 (0.69) KCNA5KCNH2
SCHEMBL3756958 0.82 KCNA5 (0.72) KCNA5KCNH2
SCHEMBL3750851 0.82 KCNA5 (0.78) KCNA5KCNH2
SCHEMBL3758883 0.82 KCNA5 (0.71) KCNA5KCNH2
SCHEMBL3762919 0.81 KCNA5 (0.65) KCNA5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049484-A1 ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS AstraZeneca AB (SE) 2009-04-22 EP claimed
WO-2008008022-A1 ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS ASTRAZENECA AB (SE) 2008-01-17 WO claimed
EP-2049484-A1 ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS AstraZeneca AB (SE) 2009-04-22 EP disclosed
WO-2008008022-A1 ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS ASTRAZENECA AB (SE) 2008-01-17 WO disclosed